Welcome to PATH

Path MembersThe Programs for Assessment of Technology in Health (PATH) Research Institute consists of multiple research programs in economic evaluation and health technology assessment (HTA).  PATH's educational and research activities are separated into 5 primary programs:  the Field Evaluation and Economic Assessment Program (FEEAP); the Health Technology Assessment Program (HTAP); the Trial and Economic Modelling Methodology Program (TEMMP); the St. Joseph's Healthcare Hamilton (SJHH) Health Technology Assessment Appraisal & Review Program (SHARP); and the Health Technology Assessment Educational Learning Program (HELP). The PATH Research Institute is affiliated with the Centre for Evaluation of Medicines (CEM) at SJHH and the Department of Clinical Epidemiology and Biostatistics at McMaster University.

Recent News

  • Just released... "Bluetooth®-enabled hearing technologies: A review of the clinical and cost-effectiveness." See Recent Reports for details.
  • PATH researchers participated at the HTAi 2010 7th Annual Meeting in Dublin, Ireland with 2 podium presentations and 7 poster displays.  See Recent Presentations for details. 
  • Elizabeth McCarron awarded the David L Sackett Prize for the best presentation by an HRM student at CE&B Research Day.
  • PATH Annual Report 2009

Recent Reports

  • Sutherland S, Gaebel K, Campbell K, Blackhouse G, Xie F, Assasi N, Doble B, Goeree R. Bluetooth®-enabled hearing technologies: A review of the clinical and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2010. pdf 
  • Gaebel K, Blackhouse G, Robertson D, Xie F, Assasi N, McIvor A, Hernandez P, Goeree R. Triple therapy for moderate-to-severe chronic obstructive pulmonary disease [Technology Report No. 127]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2010. pdf
  • Chandra K, Goeree R, Blackhouse G, Bornstein M, McMartin K, Bradley N, Franek J, Kaulback K, Taylor C. Diabetes strategy evidence platform: a summary of evidence-based analyses. Ontario Health Technology Assessment Series 2009;9(19). pdf

More Reports

Recent Presentations

  • Kaczorowski J, Chambers LW, Dolovich L, Farrell B, McDonough B, Sebaldt R, Thabane L, Tu K, Zagorski B, Goeree R, Paterson JM, Levitt C, Hogg W, Karwalajtys T, Gierman T, Laryea S, Carter M, Cross D.  Improving Cardiovascular Health at the Population Level: A 39 Community Cluster-Randomised Trial of the Cardiovascular Health Awareness Program (CHAP).  Podium presentation at the 20th European Meeting on Hypertension, Oslo, June 18-22, 2010.
  • Bowen JM, O'Reilly D, Tarride J-E, Xie F, Blackhouse G, Patterson LL, Hopkins RB, Burke N, Goeree R.  Collecting Primary Data to Support Policy Decision Making in Ontario:  Why Do We Need Different Processes for Diffused and Non-Diffused Technologies?   Podium presentation at the HTAi 2010 - 7th Annual Meeting, Dublin, Ireland, June 6-9, 2010.
  • O'Reilly D, Xie F, Pullenayegum E, Gerstein H, Greb J, Blackhouse G, Tarride J-E, Bowen J, Goeree R.  Estimation of Decreases in Health-Related Quality of Life Associated with Diabetes-Related Complications for Patients with Type 2 Diabetes in Ontario, Canada.  Podium presentation at the HTAi 2010 - 7th Annual Meeting, Dublin, Ireland, June 6-9, 2010.

More Presentations

Recent Publications

  • Hodge W, Brown A, Kymes S, Cruess A, Blackhouse G, Hopkins R, McGahan L, Sharma S, Pan I, Blair J, Vollman D, Morrison A. Pharmacologic management of neovascular age-related macular degeneration: Systematic review of economic evidence and primary economic evaluation. Canadian Journal of Ophthalmology 2010;45(3):223-30.
  • Boutis K, Willan A, Babyn P, Goeree R, Howard A, Castillo M. A randomized controlled trial of cast versus splint in children with acceptably angulated wrist fractures. CMAJ [forthcoming, 2010].
  • Manca A, Sculpher M, Goeree R. The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. PharmacoEconomics [forthcoming, 2010].
  • McCarron C, Pullenayegum EM, Thabane L, Goeree R, Tarride J.  The importance of adjusting for potential confounders in Bayesian hierarchical models synthesising evidence from randomised and non-randomised studies: an application comparing treatments for abdominal aortic aneurysms.  BMC Medical Research Methodology 2010;10:64.

More Publications